CourMed Announces 'The Oracle' Biometric Utility and $100K Investor Integration Phase

JUPITER, Fla. - Rezul -- CourMed, the global leader in Human Capital Governance, today announced the formal release of its proprietary biometric infrastructure, The Oracle. This milestone marks the transition from discretionary private client health to a permanent, secure biometric utility designed to govern the longevity of the world's most significant estates.

In a move that redefines the intersection of healthspan and wealthspan, CourMed has established a $100,000 minimum investment mandate for participation in the Fall 2026 integration phase. Access to early-stage biometric prototypes and the foundational infrastructure of The Oracle will be reserved exclusively for this vetted investment cohort.

The Founder as Prototype

In a commitment to clinical stewardship and radical accountability, CourMed Chairman Derrick L. Miles, FACHE, has announced that he is currently serving as the primary "guinea pig" for all Oracle product testing.

More on Rezul News

• 5,521 College Athletes Launch Own Merch Stores in Just 30 Days on AthleteMerch.com, Reaching 7,975 Live Storefronts Nationwide
• Altruvest and Financial Executives International Canada Announce Strategic Partnership to Strengthen Nonprofit Boards Across Canada
• Free Critical Illness Claim Calculator Launches to the Public
• Veteran Developer Launches Illinois' Only All-Ranch Custom Home Subdivision in Huntley, IL
• HRC Fertility Celebrates Beverly Hills Grand Opening, Spotlighting Fertility Care as Women's Health Month Begins

"At CourMed, we don't build products for 'cases'; we build infrastructure for Principals," said Mr. Miles. "I am personally stress-testing the utility to ensure it meets the fiduciary standards required by a Private Health Office. We are not asking our investors to trust a theory; we are inviting them to join a proven mandate."

A Fiduciary Pipeline: From Boardroom to Estate

The Oracle's deployment is managed by an elite pipeline of Management Consulting Interns. Sourced from the nation's #1-ranked program in Health Administration, these interns do not begin their training in a clinical setting. Instead, they enter CourMed's Management Consulting Cohort, where they learn to view significant estates as mini-corporations.

This ensures that every CourMed intern possesses the executive presence to act as a fiduciary for the Principal, shifting the focus from "Hospital Management" to "Human Capital Governance."

More on Rezul News

• HRC Fertility's Dr. Christo G. Zouves Appointed to San Mateo County Medical Association Board of Directors
• HealthBook+ and Stonebrook Risk Solutions Partner to Bring Predictive Intelligence to Healthcare Risk
• Umbrella Becomes First FinOps Platform to Support AWS Billing Transfer Onboarding
• RECYCLEXPERT FZE Strengthens Leadership in Data Destruction UAE and GCC with Certified Secure ITAD Services
• Assymetrix Launches the Deepest Independent Prediction Market Data API

The "Big Tech" Infrastructure

Developed with the strategic mindset encouraged by partners like Microsoft and Google, The Oracle represents a seven-year moat of proprietary data and scalable security. By move beyond "services" and into "infrastructure," CourMed has created a biological governance system that protects the human engine driving the world's most important legacies.

Fall Integration and Exclusivity

The Oracle will begin full-scale integration into select Private Health Offices in the Fall of 2026. Due to the high-touch nature of the Management Consulting Cohort and the technical requirements of the biometric utility, intake remains strictly limited to the investment cohort and existing private clients.

Learn more about CourMed and Derrick L. Miles, FACHE
https://courmed.com
https://derrickmiles.com